QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.84 (+1.39%)
F   12.01 (+0.50%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.45 (+1.64%)
AMC   4.81 (+7.86%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)
QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.84 (+1.39%)
F   12.01 (+0.50%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.45 (+1.64%)
AMC   4.81 (+7.86%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)
QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.84 (+1.39%)
F   12.01 (+0.50%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.45 (+1.64%)
AMC   4.81 (+7.86%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)
QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.84 (+1.39%)
F   12.01 (+0.50%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.45 (+1.64%)
AMC   4.81 (+7.86%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)

Travere Therapeutics (TVTX) Earnings Date, Estimates & Call Transcripts

$8.31
+0.29 (+3.62%)
(As of 02/27/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

TVTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TVTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Travere Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20244($1.20)($0.96)($1.08) 
Q2 20244($1.04)($0.65)($0.89) 
Q3 20244($0.94)($0.67)($0.82) 
Q4 20244($0.80)($0.51)($0.66) 
FY 202416($3.98)($2.79)($3.45) 
Q1 20251($0.34)($0.34)($0.34) 
Q2 20251($0.10)($0.10)($0.10) 
Q3 20251$0.07$0.07$0.07 
Q4 20251$0.14$0.14$0.14 
FY 20254($0.23)($0.23) ($0.23)

TVTX Earnings Date and Information

Travere Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off prior year's report dates.

Travere Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/2/2024
Estimated)
------- 
11/7/2023Q3 2023($1.09)($1.17)($0.08)($4.31)$132.01 million$37.10 million
8/3/2023Q2 2023($1.16)($1.13)+$0.03($1.13)$53.93 million$59.70 million
5/4/2023Q1 2023($1.18)($1.27)($0.09)($1.27)$50.93 million$56.99 million
2/23/2023Q4 2022($1.04)($1.03)+$0.01($1.03)$54.80 million$55.87 million
10/27/2022Q3 2022($0.97)($1.09)($0.12)($1.09)$51.32 million$53.50 million
8/4/2022Q2 2022($0.94)($1.05)($0.11)($1.05)$49.33 million$54.17 million
5/5/2022Q1 2022($0.85)($1.20)($0.35)($1.20)$51.92 million$48.49 million  
2/24/2022Q4 2021($0.72)($0.84)($0.12)($0.84)$56.40 million$57.25 million    
10/28/2021Q3 2021($0.72)($0.59)+$0.13($0.59)$60.93 million$68.20 million    
7/29/2021Q2 2021($0.73)($0.64)+$0.09($0.64)$50.20 million$54.62 million    
5/6/2021Q1 2021($0.56)($0.96)($0.40)($0.96)$49.99 million$47.41 million  
3/1/2021Q4 2020($0.43)($2.37)($1.94)($2.37)$51.27 million$50.98 million  












Travere Therapeutics Earnings - Frequently Asked Questions

When is Travere Therapeutics's earnings date?

Travere Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off last year's report dates. Learn more on TVTX's earnings history.

How much revenue does Travere Therapeutics generate each year?

Travere Therapeutics (NASDAQ:TVTX) has a recorded annual revenue of $145.24 million.

How much profit does Travere Therapeutics generate each year?

Travere Therapeutics (NASDAQ:TVTX) has a recorded net income of -$111.40 million. TVTX has generated -$1.61 earnings per share over the last four quarters.

What is Travere Therapeutics's EPS forecast for next year?

Travere Therapeutics's earnings are expected to grow from ($3.07) per share to ($1.73) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:TVTX) was last updated on 2/27/2024 by MarketBeat.com Staff